Morria Biopharmaceuticals PLC Report issue

For profit Phase 2
Founded: London United Kingdom (2005)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2011
NCT00867607
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

methylprednisolone (medrol) (1 trial)

mrx-6 (1 trial)

prednisone (meticorten) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 2)

Dermatitis, Allergic Contact (Phase 2)

Dermatitis, Contact (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3